Are you working with patients or clients with Parkinson’s Disease?
Parkinson’s disease is the second most common neurodegenerative disease worldwide. It is characterized by a loss of dopaminergic neurons within the substantia nigra region of the brain. This degenerative process leads to a significantly reduced quality of life and higher risk of early death.
Until now, there has never been a multi-faceted therapeutic approach for Parkinson’s. All conventional approaches are palliative-based.
We are hoping to change that by initiating the first ever medically-guided Parkinson’s Pilot Program.